Transport of Docosahexaenoic Acid via the Human Placenta: A Theoretical Study
- 57 Downloads
The high demand of the fetus for Docosahexaenoic acid, DHA, is satisfied by a concert of several mechanisms that take place in the placental terminal villi. Scarcity of laboratory data makes the detailed description of these mechanisms elusive. Here, the DHA transport across the placenta is modeled as a boundary value problem that accounts for diffusion, reactions with fatty acids binding proteins, FABPs, and metabolic consumption within the Syncytiotrophoblast, ST. For any given DHA fluxes at the bordering membranes, analytical and numerical solutions yield the DHA concentration profile within the ST. We find that in order to comply with adequate DHA delivery to the fetus and with physiological DHA concentrations in the maternal and fetal circulations, it is essential to have a significant rise of DHA concentration at the microvillus membrane, MVM and a rapid dissociation of the DHA from the FABP. The model establishes the relations between the concentrations of the FABPs in the ST, their equilibrium dissociation constant from the DHA, and the placental DHA metabolic degradation rate, hitherto unknown. We conclude that the bound (to the protein) DHA molecule is degraded at a rate of 0.3–0.45 s−1.
KeywordsDHA uptake Mathematical modeling Placenta
Compliance with Ethical Standards
Conflict of interest
The author declares that she has no conflict of interest.
Research Involving Human and Animal Rights
This article does not contain any studies with human participants or animals performed by the author.
- Durst-Zivkovic’ B, Grbesa D (1991) Stereological analysis of alpha and beta zones of syncytiotrophoblast in human term placenta. Int J Dev Biol 35(3):269–273Google Scholar
- Fats and fatty acids in human nutrition (2008) Report of an expert consultation. FAO Food and Nutrition Paper 91. GenevaGoogle Scholar
- Magnusson AL, Waterman IJ, Wennergren M, Jansson T, Powell TL (2004) Triglyceride hydrolase activities and expression of fatty acid binding proteins in human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab 89:4607–4614CrossRefGoogle Scholar
- Metherel AH, Kitson AP, Domenichiello AF, Lacombe RJS, Hopperton KE, Trepanier MO, Alashmali SM, Lin L, Bazinet RP (2017) Docosahexaenoic acid (DHA) accretion in the placenta but not the fetus is matched by plasma unesterified DHA uptake rates in pregnant Long Evans rats. Placenta 58:90–97CrossRefGoogle Scholar
- Musters MWJM, Bassingthwaighte JB, Panday V, van Riel NAW, van der Vusse GJ (2004) Computational modeling of cardiac fatty acid uptake and utilization. In: Vusse GJ (ed) Advances in molecular and cell biology, vol 33. Elsevier, Amsterdam, pp 173–221Google Scholar
- Samovski D, Dhule P, Pietka T, Jacome-Sosa M, Penrose E, Son N, Flynn RC, Shoghi KI, Hyrc KL, Goldberg IJ, Gamazon ER, Abumrad NA (2018) Regulation of insulin receptor pathway and glucose metabolism by CD36 signaling. Diabetes 67(7):1272–1284. https://doi.org/10.2337/db17-1226 CrossRefPubMedPubMedCentralGoogle Scholar